GlycoMimetics Says Edwin Rock Joins As Chief Medical Officer

RTTNews | hace 947
GlycoMimetics Says Edwin Rock Joins As Chief Medical Officer

(RTTNews) - Biotechnology company GlycoMimetics, Inc. (GLYC) announced Tuesday that Edwin Rock has joined the executive leadership team as Chief Medical Officer (CMO). Rock brings nearly two decades of biopharmaceutical clinical development experience, most recently serving as CMO for Partner Therapeutics, a privately-held commercial stage biotech.

Prior to Partner Therapeutics, as Vice President of Clinical Research at Macrogenics, Rock was clinical project leader for the first cycle approval of a successful biologics license application of margetuximab, an immune-optimized anti-HER2 antibody.

He previously served in clinical development leadership roles at Astex Pharmaceuticals, Otsuka, and GSK leading clinical trial programs for drug candidates across hematology and oncology.

Early in his career, he was a Medical Officer in oncology drug review at the U.S. FDA, as well as Vice President at Leerink Swann and Company, where he performed buyside analysis of the biotechnology sector.

read more
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Lower Canadian and U.S. futures, and weak crude oil prices point to a negative start on Bay Street Thursday morning. The focus this morning will be on U.S. consumer price inflation data, which could give some clues about the Federal Reserve's interest rate move in its next meeting.
RTTNews | hace 15 minutos
Philippine Central Bank Trims Key Rates By 25 Bps

Philippine Central Bank Trims Key Rates By 25 Bps

The Philippine central bank resumed its policy easing on Thursday, by cutting the rates by a quarter-point to address the challenges posed by trade tariffs. The Monetary Board of the Bangko Sentral ng Pilipinas decided to reduce the Target Reverse Repurchase rate by 25 basis points to 5.50 percent. The interest rates on the overnight deposit and lending facilities were accordingly reduced.
RTTNews | hace 55 minutos
FTSE 100 Up Sharply As Stocks Rally On U.S. Tariff Pause

FTSE 100 Up Sharply As Stocks Rally On U.S. Tariff Pause

U.K. stocks got off to a rousing start on Thursday, lifted by strong global cues following U.S. President Donald Trump announcing a 90-day pause of reciprocal tariffs on most U.S. trade partners, excluding China, to facilitate renewed trade negotiations.
RTTNews | hace 1h 39min
Tesco Stock Down On Weak Pre-tax Profit In FY25, Cautious Outlook

Tesco Stock Down On Weak Pre-tax Profit In FY25, Cautious Outlook

Shares of Tesco Plc were losing around 6 percent in the morning trading on the London Stoock Exchange after the British retail major reported Thursday lower pre-tax profit in fiscal year 2025 and issued a cautious outlook for fiscal 2026 adjusted operating profit. However, net profit in the year climbed from last year, with growth in revenues, and the firm lifted dividend and announced...
RTTNews | hace 2h 13min
CAC 40 Up Sharply On Trump's Tariff Pause Announcement

CAC 40 Up Sharply On Trump's Tariff Pause Announcement

French stocks are high up in positive territory on Thursday with U.S. President Donald Trump's announcement of a 90-day suspension of reciprocal tariffs for most trading partners, excluding China, buoying up sentiment and prompting investors to indulge in hectic buying across the board.
RTTNews | hace 2h 23min
DAX Up Over 5% Despite Coming Off Early Highs

DAX Up Over 5% Despite Coming Off Early Highs

German stocks are up sharply on Thursday with investors going on a buying spree after U.S. President Donald Trump announced a 90-day suspension of reciprocal tariffs for most U.S. trade partners, except China, to facilitate renewed trade negotiations.
RTTNews | hace 3h 8min
European Shares Climb On Trump Tariff Relief

European Shares Climb On Trump Tariff Relief

European stocks soared on Thursday after U.S. President Donald Trump announced a 90-day pause for countries hit by higher U.S. tariffs, with the exception of China.
RTTNews | hace 3h 36min